Annual SG&A:
$0.00-$235.78M(-100.00%)Summary
- As of today, PCRX annual SG&A is $0.00, with the most recent change of -$235.78 million (-100.00%) on December 31, 2024.
- During the last 3 years, PCRX annual SG&A has fallen by -$168.46 million (-100.00%).
- PCRX annual SG&A is now -100.00% below its all-time high of $235.78 million, reached on December 31, 2023.
Performance
PCRX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$81.65M+$4.46M(+5.77%)Summary
- As of today, PCRX quarterly SG&A is $81.65 million, with the most recent change of +$4.46 million (+5.77%) on September 30, 2025.
- Over the past year, PCRX quarterly SG&A has increased by +$16.45 million (+25.24%).
- PCRX quarterly SG&A is now at all-time high.
Performance
PCRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$815.25M+$21.44M(+2.56%)Summary
- As of today, PCRX TTM SG&A is -$815.25 million, with the most recent change of +$21.44 million (+2.56%) on September 30, 2025.
- Over the past year, PCRX TTM SG&A has dropped by -$1.06 billion (-431.57%).
- PCRX TTM SG&A is now -642.74% below its all-time high of -$109.76 million.
Performance
PCRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
PCRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | +25.2% | -431.6% |
| 3Y3 Years | -100.0% | +57.1% | -492.0% |
| 5Y5 Years | -100.0% | +83.3% | -552.1% |
PCRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | at high | +57.1% | -96.3% | +2.6% |
| 5Y | 5-Year | -100.0% | at low | at high | +100.7% | -96.3% | +44.1% |
| All-Time | All-Time | -100.0% | at low | at high | >+9999.0% | -642.7% | +48.5% |
PCRX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $81.65M(+5.8%) | $305.75M(+5.7%) |
| Jun 2025 | - | $77.19M(+1.3%) | $289.30M(+6.6%) |
| Mar 2025 | - | $76.18M(+7.7%) | $271.38M(+4.7%) |
| Dec 2024 | $0.00(-100.0%) | $70.73M(+8.5%) | $259.24M(+5.4%) |
| Sep 2024 | - | $65.20M(+10.0%) | $245.88M(+2.6%) |
| Jun 2024 | - | $59.28M(-7.4%) | $239.59M(+0.9%) |
| Mar 2024 | - | $64.04M(+11.6%) | $237.37M(+0.7%) |
| Dec 2023 | $235.78M(+7.7%) | $57.36M(-2.6%) | $235.78M(+1.2%) |
| Sep 2023 | - | $58.91M(+3.3%) | $233.08M(+3.1%) |
| Jun 2023 | - | $57.05M(-8.6%) | $226.15M(+0.3%) |
| Mar 2023 | - | $62.45M(+14.2%) | $225.56M(+3.0%) |
| Dec 2022 | $218.99M(+30.0%) | $54.66M(+5.2%) | $218.99M(+5.3%) |
| Sep 2022 | - | $51.98M(-7.9%) | $207.97M(+5.7%) |
| Jun 2022 | - | $56.46M(+1.0%) | $196.68M(+7.3%) |
| Mar 2022 | - | $55.88M(+28.0%) | $183.37M(+8.9%) |
| Dec 2021 | $168.46M(+2.5%) | $43.65M(+7.3%) | $168.46M(-0.6%) |
| Sep 2021 | - | $40.69M(-5.7%) | $169.55M(-2.2%) |
| Jun 2021 | - | $43.15M(+5.3%) | $173.41M(+3.8%) |
| Mar 2021 | - | $40.97M(-8.4%) | $167.03M(-2.2%) |
| Dec 2020 | $164.40M(-18.1%) | $44.74M(+0.4%) | $170.84M(-5.3%) |
| Sep 2020 | - | $44.55M(+21.2%) | $180.32M(-3.0%) |
| Jun 2020 | - | $36.76M(-17.9%) | $185.89M(-6.2%) |
| Mar 2020 | - | $44.78M(-17.4%) | $198.26M(-1.9%) |
| Dec 2019 | $200.78M(+13.3%) | $54.22M(+8.2%) | $202.00M(+5.0%) |
| Sep 2019 | - | $50.13M(+2.0%) | $192.42M(+3.2%) |
| Jun 2019 | - | $49.13M(+1.3%) | $186.47M(+2.7%) |
| Mar 2019 | - | $48.52M(+8.7%) | $181.59M(+2.4%) |
| Dec 2018 | $177.26M(+9.8%) | $44.65M(+1.1%) | $177.27M(+3.2%) |
| Sep 2018 | - | $44.18M(-0.2%) | $171.80M(+2.1%) |
| Jun 2018 | - | $44.25M(+0.1%) | $168.26M(+2.9%) |
| Mar 2018 | - | $44.19M(+12.8%) | $163.56M(+1.3%) |
| Dec 2017 | $161.49M | $39.18M(-3.6%) | $161.49M(+2.9%) |
| Sep 2017 | - | $40.64M(+2.8%) | $156.99M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $39.55M(-6.1%) | $152.66M(-2.6%) |
| Mar 2017 | - | $42.12M(+21.5%) | $156.78M(+2.7%) |
| Dec 2016 | $152.61M(+9.8%) | $34.67M(-4.5%) | $152.61M(+29.4%) |
| Sep 2016 | - | $36.31M(-16.8%) | $117.94M(+0.9%) |
| Jun 2016 | - | $43.67M(+15.0%) | $116.94M(+8.3%) |
| Mar 2016 | - | $37.96M(>+9900.0%) | $108.02M(+6.4%) |
| Dec 2015 | $139.04M(+30.4%) | $0.00(-100.0%) | $101.49M(-23.4%) |
| Sep 2015 | - | $35.31M(+1.6%) | $132.51M(+5.7%) |
| Jun 2015 | - | $34.75M(+10.6%) | $125.42M(+8.6%) |
| Mar 2015 | - | $31.43M(+1.3%) | $115.50M(+8.3%) |
| Dec 2014 | $106.66M(+70.6%) | $31.02M(+9.9%) | $106.66M(+11.3%) |
| Sep 2014 | - | $28.22M(+13.6%) | $95.81M(+15.6%) |
| Jun 2014 | - | $24.84M(+10.0%) | $82.92M(+14.9%) |
| Mar 2014 | - | $22.59M(+12.0%) | $72.16M(+15.4%) |
| Dec 2013 | $62.51M(+35.0%) | $20.17M(+31.7%) | $62.51M(+12.2%) |
| Sep 2013 | - | $15.32M(+8.8%) | $55.70M(+7.6%) |
| Jun 2013 | - | $14.08M(+8.8%) | $51.76M(+7.6%) |
| Mar 2013 | - | $12.94M(-3.2%) | $48.09M(+3.9%) |
| Dec 2012 | $46.31M(+129.7%) | $13.36M(+17.4%) | $46.31M(+16.8%) |
| Sep 2012 | - | $11.38M(+9.3%) | $39.64M(+19.2%) |
| Jun 2012 | - | $10.41M(-6.6%) | $33.25M(+20.9%) |
| Mar 2012 | - | $11.15M(+66.6%) | $27.50M(+36.4%) |
| Dec 2011 | $20.16M(+234.3%) | $6.69M(+34.2%) | $20.16M(+29.6%) |
| Sep 2011 | - | $4.99M(+6.8%) | $15.55M(+7.2%) |
| Jun 2011 | - | $4.67M(+22.8%) | $14.51M(+31.0%) |
| Mar 2011 | - | $3.81M(+82.1%) | $11.07M(+33.7%) |
| Dec 2010 | $6.03M(+20.1%) | $2.09M(-47.0%) | $8.28M(+13.6%) |
| Sep 2010 | - | $3.94M(+218.3%) | $7.29M(+47.6%) |
| Jun 2010 | - | $1.24M(+22.5%) | $4.94M(+33.4%) |
| Mar 2010 | - | $1.01M(-8.1%) | $3.70M(+37.6%) |
| Dec 2009 | $5.02M(-41.7%) | $1.10M(-30.9%) | $2.69M(+69.1%) |
| Sep 2009 | - | $1.59M | $1.59M |
| Dec 2008 | $8.61M(+103.8%) | - | - |
| Dec 2007 | $4.22M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual SG&A?
- What is the all-time high annual SG&A for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual SG&A year-on-year change?
- What is Pacira BioSciences, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly SG&A year-on-year change?
- What is Pacira BioSciences, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM SG&A year-on-year change?
What is Pacira BioSciences, Inc. annual SG&A?
The current annual SG&A of PCRX is $0.00
What is the all-time high annual SG&A for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual SG&A is $235.78M
What is Pacira BioSciences, Inc. annual SG&A year-on-year change?
Over the past year, PCRX annual SG&A has changed by -$235.78M (-100.00%)
What is Pacira BioSciences, Inc. quarterly SG&A?
The current quarterly SG&A of PCRX is $81.65M
What is the all-time high quarterly SG&A for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly SG&A is $81.65M
What is Pacira BioSciences, Inc. quarterly SG&A year-on-year change?
Over the past year, PCRX quarterly SG&A has changed by +$16.45M (+25.24%)
What is Pacira BioSciences, Inc. TTM SG&A?
The current TTM SG&A of PCRX is -$815.25M
What is the all-time high TTM SG&A for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM SG&A is -$109.76M
What is Pacira BioSciences, Inc. TTM SG&A year-on-year change?
Over the past year, PCRX TTM SG&A has changed by -$1.06B (-431.57%)